期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 92, 期 -, 页码 105-122出版社
ELSEVIER
DOI: 10.1016/j.addr.2015.06.008
关键词
Vaginal bacteriosis; Bacterial vaginosis; Vulvovaginal candidosis; Trichomoniasis; Bioadhesive formulations; Thermogelling systems; Plant extracts; Vaginal dosage forms
Vaginal infections are extremely prevalent, particularly among women of reproductive age. Although they do not result in high mortality rates, these infections are associated with high levels of anxiety and reduction of quality of life. In most cases, topical treatment of vaginal infections has been shown to be at least as effective as oral treatment, resulting in higher local drug concentrations, with fewer drug interactions and adverse effects. Furthermore, the emergence of microbial resistance to chemotherapeutics and the difficulties in managing infection recurrences sustain the need for more effective local treatments. However, conventional dosage forms have been associated with low retention in the vagina and discomfort. Formulation strategies such as the development of bioadhesive, thermogelling systems and microtechnological or nanotechnological approaches have been proposed to improve delivery of traditional drugs, and other treatment modalities such as new drugs, plant extracts, and probiotics are being studied. This article reviews the recent strategies studied to improve the treatment and prevention of the commonest vaginal infections namely, vaginal bacteriosis, aerobic vaginitis, vulvovaginal candidosis, and trichomoniasis through the intravaginal route. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据